Zarxio
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
To assess the capture of biologics (originator and biosimilar) in the Biologics and Biosimilars Collective Intelligence…
e18334Background: Biosimilar filgrastim (Zarxio) provides a more cost-efficient alternative to reference and pegylated filgrastim…
Sandoz’s biosimilar drug is about to become the first drug approved under the FDA’s biosimilar pathway. On January 7, the US Food…
FDA approved filgrastim-sndz (Zarxio, Sandoz), the first biosimilar product approved in the United States.